Sun Pharma Q1 Results: Sun Pharma announced its results for the quarter ended June 2025 (Q1FY26) today, July 31. The pharma stock’s consolidated net profit fell 20 percent to ₹2,279 crore in Q1FY26 as against ₹2,835 crore in the same period last year. Sequentially, the profit rose 6 percent from ₹2150 crore in the March quarter.
The consolidated revenue of the company rose over 9 percent to ₹13,851 crore in the June 2025 quarter from ₹12,653 crore in Q1FY25 in the quarter under review.
